Additionally, Cardillo et al. demonstrated that selective blockade of the endothelin-A receptor in patients with diabetes leads to vasodilation, suggesting an increased activity of the ET-1-ETAR pathway [50]. Here, EDN1 is linked to diabetes mellitus.